Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals
- 18 April 2025
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (2) , 250-258
Abstract
Background: Biomarkers of low-grade systemic inflammation have been reported to be higher in patients with psoriasis than in healthy controls. However, it is unknown whether this low-grade systemic inflammation contributes to the development of psoriasis or is merely a consequence. Objectives: To investigate whether low-grade systemic inflammation, measured as systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR) or C-reactive protein (CRP), is an independent risk factor for psoriasis. Methods: We used data from the Copenhagen General Population Study, a prospective cohort study of the Danish general population where individuals aged 20–100 years were enrolled between 2003 and 2015. Upon enrolment in the study, all individuals underwent a physical examination, completed an extensive self-reported questionnaire regarding lifestyle, and provided blood samples, from which SII, NLR and CRP were measured. Psoriasis was identified using International Classification of Diseases codes with individual linkage to the Danish National Patient Registry. Associations between SII, NLR and CRP and psoriasis were estimated using hazard ratios from Cox proportional hazard regression models. Analyses were adjusted for potential confounders including sex, age, smoking, alcohol consumption, physical activity, educational level, hypertension, dyslipidaemia and obesity. Results: We included 105 418 individuals with a median age of 58 years, 55% of whom were women. The risk of receiving a diagnosis of psoriasis increased with increasing levels of SII, NLR and CRP. In individuals with high levels (> 90th percentile) of SII, NLR and CRP, the multivariable adjusted hazard ratios were 1.78 [95% confidence interval (CI) 1.41–2.24], 1.56 (95% CI 1.22–1.99) and 2.83 (95% CI 2.27–3.51), respectively, compared with individuals with low levels. Results were similar but slightly attenuated when we used topical calcipotriol (alone or in combination with corticosteroids) for mild psoriasis. Conclusions: We found that low-grade systemic inflammation, as measured by SII, NLR and CRP, was an independent risk factor for psoriasis, especially moderate-to-severe disease. These findings support the hypothesis that low-grade systemic inflammation may contribute to the pathogenesis of psoriasis rather than simply being a consequence of the disease.Keywords
Funding Information
- Capital Region of Denmark
This publication has 41 references indexed in Scilit:
- Exploring the Link Between Genetic Predictors of Cardiovascular Disease and PsoriasisJAMA Cardiology, 2024
- Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysisArchives of Dermatological Research, 2024
- Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patientsJournal of Allergy and Clinical Immunology, 2021
- Cardiovascular Risk in Patients With PsoriasisJACC, 2021
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Neutrophil Subsets, Platelets, and Vascular Disease in PsoriasisJACC: Basic To Translational Science, 2019
- Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysisClinical and Experimental Medicine, 2018
- The Danish Civil Registration System as a tool in epidemiologyEuropean Journal of Epidemiology, 2014
- Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 IndividualsJAMA Psychiatry, 2013
- Platelet activation in patients with psoriasis: Increased plasma levels of platelet-derived microparticles and soluble P-selectinJournal of the American Academy of Dermatology, 2010